Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision label on the page has been updated from v3.6.2 to v3.6.3, indicating a minor version update to the page metadata. This change does not reflect a substantive update to the study content or visible information.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend or CMS update with no visible changes to study information.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded recruitment status note 'No longer looking for participants' and new navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with an updated Revision: v3.6.0. Replaced the heading 'Intervention / Treatment' with 'Intervention/Treatment' and removed the older 'Revision: v3.5.5' tag.SummaryDifference0.4%

- Check39 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This indicates a new version of the document.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a newer platform revision tag. This change does not modify study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page’s footer release/revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical trial study details.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.